{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:55:22Z","timestamp":1790229322792,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>Assessment of the Ki67 index is critical for grading well-differentiated neuroendocrine tumors (WD-NETs), which can show a broad range of labeling that defines the WHO grade (G1-G3). Poorly differentiated neuroendocrine carcinomas (PD-NECs) have a relatively high Ki67 index, &gt;20% in all cases and commonly exceeding 50%. After anecdotally observing PD-NECs with an unexpectedly low and heterogeneous Ki67 index following chemotherapy in 5 cases, we identified 15 additional cases of treated high-grade neuroendocrine neoplasms (HG-NENs). The study cohort comprised 20 cases; 11 PD-NECs, 8 mixed adenoneuroendocrine carcinomas, and 1 WD-NET, G3 from various anatomic sites (gastrointestinal tract, pancreas, larynx, lung, and breast). The Ki67 index was evaluated on pretreatment (when available) and posttreatment samples. Topographic heterogeneity in the Ki67 index was expressed using a semi-quantitative score of 0 (no heterogeneity) to 5 (&gt;80% difference between maximal Ki67 and minimal Ki67 indices). Relative to the pretreatment group (n=9, mean Ki67 of 86.3%, range 80% to 100%), the neoplasms in the posttreatment group (n=20, mean Ki67 of 47.7%, range 1% to 90%) showed a significantly lower Ki67 index (18\/20 cases). Of the 18 cases with a relatively low Ki67 index, 15 showed heterogeneous labeling (mean heterogeneity score of 2.3, range 1 to 5) and in 3 cases it was a homogeneously low. This phenomenon was observed in all subtypes of HG-NENs. In 6 cases, the alterations in Ki67 index following treatment were sufficient to place these HG-NENs in the WHO G1 or G2 grade, erroneously suggesting a diagnosis of WD-NET, and in 9 cases there was sufficient heterogeneity in the Ki67 index to suggest that a limited biopsy may sample an area of low Ki67, even though hotspot regions with a Ki67 index of &gt;20% persisted. In 7 cases, the alterations in the Ki67 index were accompanied by morphologic features resembling a WD-NET. These observations suggest that there is a potential for misinterpretation of previously treated PD-NECs as WD-NETs, or for assigning a lower grade in G3 WD-NETs. While the prognostic significance of treatment-associated alterations in Ki67 index is unknown, awareness of this phenomenon is important to avoid this diagnostic pitfall when evaluating treated NENs.<\/jats:p>","DOI":"10.1097\/pas.0000000000001602","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T18:17:27Z","timestamp":1605118647000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Alterations in Ki67 Labeling Following Treatment of Poorly Differentiated Neuroendocrine Carcinomas"],"prefix":"10.1097","volume":"45","author":[{"given":"Monika","family":"Vyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Rekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/PAS.0000000000000662","article-title":"A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas","volume":"40","author":"Tang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/1078-0432.CCR-15-0548","article-title":"Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas","volume":"22","author":"Tang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","article-title":"Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms","volume":"27","author":"La Rosa","year":"2016","journal-title":"Endocr Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000478-200402000-00009","article-title":"Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome","volume":"28","author":"Shia","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000481390","article-title":"Neuroendocrine neoplasms: dichotomy, origin and classifications","volume":"33","author":"Kloppel","year":"2017","journal-title":"Visc Med"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"40609","DOI":"10.1038\/srep40609","article-title":"Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers","volume":"7","author":"Freis","year":"2017","journal-title":"Sci Rep"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12902-018-0274-y","article-title":"Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms\u2014a single-center retrospective study","volume":"18","author":"Shi","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.ejso.2014.06.016","article-title":"Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease","volume":"40","author":"Singh","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2217\/ije-2016-0006","article-title":"The ENETS\/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications","volume":"3","author":"Cavalcanti","year":"2016","journal-title":"Int J Endocr Oncol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/PAS.0b013e31821a0696","article-title":"Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification","volume":"35","author":"Yang","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1200\/JCO.1991.9.1.50","article-title":"Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma","volume":"9","author":"Brambilla","year":"1991","journal-title":"J Clin Oncol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1159\/000484473","article-title":"Downgrading of a G3 neuroendocrine tumor to a G2 tumor: can first-line cytotoxic chemotherapy change the tumor biology","volume":"10","author":"Blesl","year":"2017","journal-title":"Case Rep Oncol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00000478-200207000-00004","article-title":"Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy","volume":"26","author":"Shia","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0344-0338(97)80076-3","article-title":"Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer","volume":"193","author":"Moll","year":"1997","journal-title":"Pathol Res Pract"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.55.1.27","article-title":"Morphological effects of chemotherapy on ovarian carcinoma","volume":"55","author":"McCluggage","year":"2002","journal-title":"J Clin Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/mpo.2950100308","article-title":"Induction of neuroblastoma maturation by a new chemotherapy protocol","volume":"10","author":"Raaf","year":"1982","journal-title":"Med Pediatr Oncol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/bjc.1994.303","article-title":"The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma","volume":"70","author":"Rasbridge","year":"1994","journal-title":"Br J Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:04:41Z","timestamp":1749420281000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001602"}},"subtitle":["A Potential Diagnostic Pitfall"],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001602","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,10]]}}}